[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Nuclear Medicine/Radiopharmaceutic Sales Market Report 2018

March 2018 | 112 pages | ID: GD8F4DDC861QEN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the global Nuclear Medicine/Radiopharmaceutic market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split global into several key Regions, with sales (M Dose), revenue (Million USD), market share and growth rate of Nuclear Medicine/Radiopharmaceutic for these regions, from 2013 to 2025 (forecast), covering
  • United States
  • China
  • Europe
  • Japan
  • Southeast Asia
  • India
Global Nuclear Medicine/Radiopharmaceutic market competition by top manufacturers/players, with Nuclear Medicine/Radiopharmaceutic sales volume, Price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Company
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Oncology
  • Cardiology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Nuclear Medicine/Radiopharmaceutic Sales Market Report 2018

1 NUCLEAR MEDICINE/RADIOPHARMACEUTIC MARKET OVERVIEW

1.1 Product Overview and Scope of Nuclear Medicine/Radiopharmaceutic
1.2 Classification of Nuclear Medicine/Radiopharmaceutic by Product Category
  1.2.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Nuclear Medicine/Radiopharmaceutic Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Diagnostic Radioisotopes
  1.2.4 Therapeutic Radioisotopes
1.3 Global Nuclear Medicine/Radiopharmaceutic Market by Application/End Users
  1.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.2 Oncology
  1.3.3 Cardiology
  1.3.4 Others
1.4 Global Nuclear Medicine/Radiopharmaceutic Market by Region
  1.4.1 Global Nuclear Medicine/Radiopharmaceutic Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.3 China Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.4 Europe Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.5 Japan Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
  1.4.7 India Nuclear Medicine/Radiopharmaceutic Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Nuclear Medicine/Radiopharmaceutic (2013-2025)
  1.5.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2025)
  1.5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2025)

2 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTIC COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Nuclear Medicine/Radiopharmaceutic Market Competition by Players/Suppliers
  2.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Type
  2.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Type (2013-2018)
  2.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2013-2018)
2.3 Global Nuclear Medicine/Radiopharmaceutic (Volume and Value) by Region
  2.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales and Market Share by Region (2013-2018)
  2.3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Region (2013-2018)
2.4 Global Nuclear Medicine/Radiopharmaceutic (Volume) by Application

3 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

3.1 United States Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  3.1.1 United States Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2018)
  3.1.2 United States Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  3.1.3 United States Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
3.2 United States Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Players (2013-2018)
3.3 United States Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type (2013-2018)
3.4 United States Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application (2013-2018)

4 CHINA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

4.1 China Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  4.1.1 China Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2018)
  4.1.2 China Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  4.1.3 China Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
4.2 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Players (2013-2018)
4.3 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type (2013-2018)
4.4 China Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application (2013-2018)

5 EUROPE NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  5.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2018)
  5.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  5.1.3 Europe Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
5.2 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application (2013-2018)

6 JAPAN NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  6.1.1 Japan Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2018)
  6.1.2 Japan Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
6.2 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  7.1.1 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
7.2 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application (2013-2018)

8 INDIA NUCLEAR MEDICINE/RADIOPHARMACEUTIC (VOLUME, VALUE AND SALES PRICE)

8.1 India Nuclear Medicine/Radiopharmaceutic Sales and Value (2013-2018)
  8.1.1 India Nuclear Medicine/Radiopharmaceutic Sales and Growth Rate (2013-2018)
  8.1.2 India Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate (2013-2018)
  8.1.3 India Nuclear Medicine/Radiopharmaceutic Sales Price Trend (2013-2018)
8.2 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Players (2013-2018)
8.3 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Type (2013-2018)
8.4 India Nuclear Medicine/Radiopharmaceutic Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTIC PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Company
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Company Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Bracco Imaging
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Bayer
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Mallinckrodt
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 Nordion
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Triad Isotopes
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Lantheus
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Lantheus Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 IBA Group
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 IBA Group Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 GE Healthcare
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 China Isotope & Radiation
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Nuclear Medicine/Radiopharmaceutic Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Jubilant Pharma
9.12 Eli Lilly
9.13 Advanced Accelerator Applications
9.14 SIEMENS
9.15 Dongcheng
9.16 Navidea

10 NUCLEAR MEDICINE/RADIOPHARMACEUTIC MAUFACTURING COST ANALYSIS

10.1 Nuclear Medicine/Radiopharmaceutic Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
10.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTIC MARKET FORECAST (2018-2025)

14.1 Global Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Nuclear Medicine/Radiopharmaceutic Price and Trend Forecast (2018-2025)
14.2 Global Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Nuclear Medicine/Radiopharmaceutic Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 China Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 Europe Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Nuclear Medicine/Radiopharmaceutic Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2018-2025)
  14.3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2018-2025)
  14.3.3 Global Nuclear Medicine/Radiopharmaceutic Price Forecast by Type (2018-2025)
14.4 Global Nuclear Medicine/Radiopharmaceutic Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Nuclear Medicine/Radiopharmaceutic
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Volume Comparison (M Dose) by Type (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (Product Category) in 2017
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Comparison (M Dose) by Application (2013-2025)
Figure Global Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application in 2017
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Nuclear Medicine/Radiopharmaceutic Market Size (Million USD) by Regions (2013-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate (2013-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Sales (M Dose) of Key Players/Suppliers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
Figure 2017 Nuclear Medicine/Radiopharmaceutic Sales Share by Players/Suppliers
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
Table 2017 Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Players
Table Global Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Market Share by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share (M Dose) by Type (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Type (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Type (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Market Share by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share by Region (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate by Region in 2017
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate by Region in 2017
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Nuclear Medicine/Radiopharmaceutic by Region (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region in 2017
Table Global Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Market Share by Application (2013-2018)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Nuclear Medicine/Radiopharmaceutic by Application (2013-2018)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Players (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players in 2017
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Application (2013-2018)
Table United States Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure China Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Players (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players in 2017
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Application (2013-2018)
Table China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Players (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players in 2017
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Application (2013-2018)
Table Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Players (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players in 2017
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Application (2013-2018)
Table Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Players (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players in 2017
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Application (2013-2018)
Table Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Figure India Nuclear Medicine/Radiopharmaceutic Sales (M Dose) and Growth Rate (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Price (USD/Dose) Trend (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Players (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Players in 2017
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Type (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Type in 2017
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) by Application (2013-2018)
Table India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application (2013-2018)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share by Application in 2017
Table Company Basic Information List
Table Company Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018)
Figure Company Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table Bracco Imaging Basic Information List
Table Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table Bayer Basic Information List
Table Bayer Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Bayer Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018
Figure Bayer Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table Mallinckrodt Basic Information List
Table Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table Nordion Basic Information List
Table Nordion Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018)
Figure Nordion Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table Triad Isotopes Basic Information List
Table Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018
Figure Triad Isotopes Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table Lantheus Basic Information List
Table Lantheus Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018)
Figure Lantheus Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table IBA Group Basic Information List
Table IBA Group Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018
Figure IBA Group Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table GE Healthcare Basic Information List
Table GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table China Isotope & Radiation Basic Information List
Table China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (M Dose), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales Growth Rate (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales Global Market Share (2013-2018)
Figure China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Revenue Global Market Share (2013-2018)
Table Jubilant Pharma Basic Information List
Table Eli Lilly Basic Information List
Table Advanced Accelerator Applications Basic Information List
Table SIEMENS Basic Information List
Table Dongcheng Basic Information List
Table Navidea Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nuclear Medicine/Radiopharmaceutic
Figure Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic
Figure Nuclear Medicine/Radiopharmaceutic Industrial Chain Analysis
Table Raw Materials Sources of Nuclear Medicine/Radiopharmaceutic Major Players in 2017
Table Major Buyers of Nuclear Medicine/Radiopharmaceutic
Table Distributors/Traders List
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) and Trend Forecast (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share Forecast by Regions in 2025
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Regions in 2025
Figure United States Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure United States Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure China Nuclear Medicine/Radiopharmaceutic Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure Europe Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure Japan Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Sales Volume (M Dose) and Growth Rate Forecast (2018-2025)
Figure India Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Sales (M Dose) Forecast by Type (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Price (USD/Dose) Forecast by Type (2018-2025)
Table Global Nuclear Medicine/Radiopharmaceutic Sales (M Dose) Forecast by Application (2018-2025)
Figure Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications